ConductScience.org, home

Paper20430905

Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients.

Lim YW and 12 others. Ann Oncol, 2010. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients. Papers, record 20430905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20430905

Download JSON
Disease
breast cancer1,032 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients.
PubMed
Journal
Ann Oncol
PubMed
Year
2010
PubMed
Publication types
Clinical Trial, Phase II, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2020-06-26
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lim YWY-W
2Goh BCB-C
3Wang LZL-Z
4Tan SHS-H
5Chuah BYSB Y S
6Lim SES-E
7Iau PP
8Buhari SAS A
9Chan CWC-W
10Sukri NBN B
11Cordero MTM T
12Soo RR
13Lee SCS-C

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
Area Under Curve
Docetaxel
Drug Therapy, Combination
Female
Humans
Ketoconazole
Maximum Tolerated Dose
Neoplasm Staging
Survival Rate
Taxoids
Treatment Outcome

Source PubMed

Download CSV of topics

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00212082Gene Expression Profiles in Predicting Chemotherapy Response in Breast CancerDerived from the trialYesClinicalTrials.gov
NCT00212095Docetaxel Combined With Ketoconazole in Treatment of Breast CancerDerived from the trialYesClinicalTrials.gov
NCT01227733Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput PlatformsBackgroundClinicalTrials.gov
NCT01247467Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - a Pilot StudyBackgroundClinicalTrials.gov

Download CSV of trials

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
41262581Crescent-Shaped Xanthone-Benzimidazole Conjugates as New Target Probes for Telomeric G‑Quadruplex DNA and Specific Cytotoxicity on Cancer Cells.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/41262581PubMed
39768178Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers.Cells2024https://conductscience.org/library/papers/39768178PubMed
39161139A Cross-sectional Comparative Analysis of Eleven Population Pharmacokinetic Models for Docetaxel in Chinese Breast Cancer Patients.Curr Drug Metab2024https://conductscience.org/library/papers/39161139PubMed
36077791
An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1.
Cancers (Basel)2022https://conductscience.org/library/papers/36077791PubMed
36067975Repurposing antifungal drugs for cancer therapy.J Adv Res2023https://conductscience.org/library/papers/36067975PubMed
35399310Influence of Concomitant Polypharmacy on Docetaxel-induced Febrile Neutropenia.Cancer Diagn Progn2021https://conductscience.org/library/papers/35399310PubMed
35378926Clotrimazole Inhibits HCC Migration and Invasion by Modulating the ERK-p65 Signaling Pathway.Drug Des Devel Ther2022https://conductscience.org/library/papers/35378926PubMed
35083840Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis.Small2022https://conductscience.org/library/papers/35083840PubMed
33986386Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma.Sci Rep2021https://conductscience.org/library/papers/33986386PubMed
33062889ARe we there yet? Understanding androgen receptor signaling in breast cancer.NPJ Breast Cancer2020https://conductscience.org/library/papers/33062889PubMed
30481959Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.ACS Nano2018https://conductscience.org/library/papers/30481959PubMed
28496479A Comparison of Hepatocyte Cytotoxic Mechanisms for Docetaxel and PLGA-Docetaxel Nanoparticls.Iran J Pharm Res2017https://conductscience.org/library/papers/28496479PubMed
26582454Pharmacokinetics and safety of cyclophosphamide and docetaxel in a hemodialysis patient with early stage breast cancer: a case report.BMC Cancer2015https://conductscience.org/library/papers/26582454PubMed
21692829Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report.Br J Clin Pharmacol2011https://conductscience.org/library/papers/21692829PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576

Source NCBI Gene

Download CSV of genes

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
KETOCONAZOLECHEMBL157101Derived from the trial1https://conductscience.org/library/drugs/CHEMBL157101ChEMBL
DOCETAXELCHEMBL3545252Derived from the trial2https://conductscience.org/library/drugs/CHEMBL3545252ChEMBL
DOXORUBICINCHEMBL53463Derived from the trial1https://conductscience.org/library/drugs/CHEMBL53463ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20430905

GET https://conductscience.org/api/papers/v1/20430905/authors